Mario Caccese

1.6k total citations
70 papers, 883 citations indexed

About

Mario Caccese is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mario Caccese has authored 70 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Genetics, 29 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Mario Caccese's work include Glioma Diagnosis and Treatment (51 papers), Brain Metastases and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Mario Caccese is often cited by papers focused on Glioma Diagnosis and Treatment (51 papers), Brain Metastases and Treatment (17 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Mario Caccese collaborates with scholars based in Italy, France and United States. Mario Caccese's co-authors include Giuseppe Lombardi, Vittorina Zagonel, Giulia Cerretti, Marta Padovan, Ahmed Idbaïh, Stefano Indraccolo, Cristina Birzu, Pim J. French, Giampaolo Tortora and Sara Pilotto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Mario Caccese

60 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Caccese Italy 17 450 253 242 224 211 70 883
Katharina Seystahl Switzerland 16 434 1.0× 230 0.9× 192 0.8× 196 0.9× 147 0.7× 40 867
Ryusuke Hatae Japan 17 554 1.2× 295 1.2× 216 0.9× 154 0.7× 227 1.1× 56 979
Ivan Lolli Italy 13 388 0.9× 158 0.6× 190 0.8× 197 0.9× 202 1.0× 40 672
Luisa Bellu Italy 13 465 1.0× 162 0.6× 128 0.5× 218 1.0× 158 0.7× 43 690
Lindsay Kilburn United States 17 637 1.4× 462 1.8× 189 0.8× 178 0.8× 177 0.8× 68 1.1k
Marina Faedi Italy 13 412 0.9× 157 0.6× 199 0.8× 213 1.0× 164 0.8× 27 710
Elizabeth Cohen‐Jonathan‐Moyal France 14 558 1.2× 519 2.1× 217 0.9× 202 0.9× 337 1.6× 25 1.2k
Brian Thiessen Canada 16 687 1.5× 412 1.6× 220 0.9× 295 1.3× 244 1.2× 32 1.2k
Ziren Kong China 18 395 0.9× 185 0.7× 231 1.0× 188 0.8× 130 0.6× 47 878
Gina Lama Italy 17 302 0.7× 286 1.1× 197 0.8× 187 0.8× 172 0.8× 27 931

Countries citing papers authored by Mario Caccese

Since Specialization
Citations

This map shows the geographic impact of Mario Caccese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Caccese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Caccese more than expected).

Fields of papers citing papers by Mario Caccese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Caccese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Caccese. The network helps show where Mario Caccese may publish in the future.

Co-authorship network of co-authors of Mario Caccese

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Caccese. A scholar is included among the top collaborators of Mario Caccese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Caccese. Mario Caccese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voltan, Giacomo, Renzo Manara, Mario Caccese, et al.. (2025). Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study. Pituitary. 28(5). 102–102.
2.
Cerretti, Giulia, et al.. (2024). Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion. Neuro-Oncology Advances. 6(1). vdae077–vdae077.
3.
Crimì, Filippo, Maurizio Iacobone, Francesca Torresan, et al.. (2024). Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma. Journal of Endocrinological Investigation. 48(3). 711–720. 1 indexed citations
4.
Cerretti, Giulia, Marta Padovan, Cândida Toni, et al.. (2023). 502MO Target therapy matched to genomic alterations in patients with recurrent IDH wildtype glioblastoma: A real-life cohort analysis from Veneto Institute of Oncology, Padua (Italy). Annals of Oncology. 34. S393–S393. 2 indexed citations
5.
Caccese, Mario, Susanna Mandruzzato, Alba Fiorentino, et al.. (2023). Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities. The Oncologist. 29(4). 289–302. 10 indexed citations
6.
Caccese, Mario, F. Busato, Angela Guerriero, et al.. (2023). The role of radiation therapy and systemic treatments in meningioma: The present and the future. Cancer Medicine. 12(15). 16041–16053. 5 indexed citations
7.
Bosio, Albino Claudio, Giulia Cerretti, Marta Padovan, et al.. (2023). Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study. Clinical Oncology. 35(5). e319–e327. 3 indexed citations
8.
9.
Caccese, Mario, Isacco Desideri, Marta Padovan, et al.. (2023). Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. Journal of Neuro-Oncology. 163(2). 377–383. 2 indexed citations
10.
Cerretti, Giulia, Federico Pessina, Enrico Franceschi, et al.. (2023). Spinal ependymoma in adults: from molecular advances to new treatment perspectives. Frontiers in Oncology. 13. 1301179–1301179. 5 indexed citations
11.
Pace, Andrea, Giuseppe Lombardi, Veronica Villani, et al.. (2023). Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial. Frontiers in Oncology. 13. 1320710–1320710. 6 indexed citations
12.
Simonelli, Matteo, Mario Caccese, Delphine Larrieu‐Ciron, et al.. (2023). CTIM-32. A PARALLEL COHORT PHASE 2 STUDY OF REGORAFENIB PLUS NIVOLUMAB FOR RECURRENT OR METASTATIC SOLID TUMORS: RESULTS IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR ANAPLASTIC ASTROCYTOMA (AA). Neuro-Oncology. 25(Supplement_5). v69–v70. 1 indexed citations
13.
Indraccolo, Stefano, Gian Luca De Salvo, Mario Caccese, et al.. (2020). Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis. Clinical Cancer Research. 26(17). 4478–4484. 28 indexed citations
14.
Salani, Francesca, Irene Pecora, Caterina Vivaldi, et al.. (2020). P-219 Clear cell variant of hepatocellular carcinoma (HCC-CC): A single-center observational study of an uncommon subtype. Annals of Oncology. 31. S161–S162.
15.
Caccese, Mario, Marta Padovan, Domenico D’Avella, et al.. (2020). Anaplastic Astrocytoma: State of the art and future directions. Critical Reviews in Oncology/Hematology. 153. 103062–103062. 12 indexed citations
16.
Parrozzani, Raffaele, Giuseppe Lombardi, Edoardo Midena, et al.. (2020). Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study. Frontiers in Oncology. 10. 593461–593461. 12 indexed citations
17.
Caccese, Mario, Stefano Indraccolo, Vittorina Zagonel, & Giuseppe Lombardi. (2019). PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review. Critical Reviews in Oncology/Hematology. 135. 128–134. 75 indexed citations
18.
Noia, Vincenzo Di, Ettore D’Argento, Sara Pilotto, et al.. (2018). Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies. Expert Opinion on Biological Therapy. 18(9). 937–945. 12 indexed citations
19.
Peretti, Umberto, Roberto Ferrara, Sara Pilotto, et al.. (2016). ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations. Respiratory Research. 17(1). 105–105. 9 indexed citations
20.
Pilotto, Sara, Silvia Novello, Umberto Peretti, et al.. (2015). An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer. Expert Opinion on Investigational Drugs. 24(9). 1143–1161. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Seystahl Breakdown of academic impact, for papers by Ryusuke Hatae Breakdown of academic impact, for papers by Ivan Lolli Breakdown of academic impact, for papers by Luisa Bellu Breakdown of academic impact, for papers by Lindsay Kilburn Breakdown of academic impact, for papers by Marina Faedi Breakdown of academic impact, for papers by Elizabeth Cohen‐Jonathan‐Moyal Breakdown of academic impact, for papers by Brian Thiessen Breakdown of academic impact, for papers by Ziren Kong Breakdown of academic impact, for papers by Gina Lama
Rankless by CCL
2026